Impact of Dapagliflozin Therapy on Renal Protection and Kidney Morphology in Patients With Uncontrolled Type 2 Diabetes Mellitus

BACKGROUND: We examined whether the sodium-glucose cotransporter-2 inhibitor (SGLT2i) dapagliflozin can improve urine albumin-to-creatinine ratio (UACR) associated with a reduction in body weight or body fat in patients with type 2 diabetes mellitus (T2DM). METHODS: We prospectively recruited T2DM p...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugiyama, Seigo, Jinnouchi, Hideaki, Kurinami, Noboru, Hieshima, Kunio, Yoshida, Akira, Jinnouchi, Katsunori, Tanaka, Motoko, Nishimura, Hiroyuki, Suzuki, Tomoko, Miyamoto, Fumio, Kajiwara, Keizo, Jinnouchi, Tomio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916535/
https://www.ncbi.nlm.nih.gov/pubmed/29707088
http://dx.doi.org/10.14740/jocmr3419w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916535/
https://www.ncbi.nlm.nih.gov/pubmed/29707088
http://dx.doi.org/10.14740/jocmr3419w

Ejemplares similares